Geode Capital Management
IPSC icon

Geode Capital Management’s Century Therapeutics IPSC Stock Holding History

Geode Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.94M Buy
1,301,664
+845,549
+185% +$1.78M ﹤0.01% 2979
2025
Q4 		$454K Buy
456,115
+10,806
+2% +$6.59K ﹤0.01% 3617
2025
Q3 		$222K Buy
445,309
+65,032
+17% +$35.1K ﹤0.01% 3890
2025
Q2 		$213K Sell
380,277
-589,983
-61% -$317K ﹤0.01% 3853
2025
Q1 		$462K Sell
970,260
-21,335
-2% -$16K ﹤0.01% 3570
2024
Q4 		$1M Buy
991,595
+23,413
+2% +$31.9K ﹤0.01% 3377
2024
Q3 		$1.66M Buy
968,182
+32,614
+3% +$63.9K ﹤0.01% 3188
2024
Q2 		$2.39M Buy
935,568
+424,977
+83% +$1.34M ﹤0.01% 3072
2024
Q1 		$2.13M Buy
510,591
+42,134
+9% +$178K ﹤0.01% 3092
2023
Q4 		$1.56M Buy
468,457
+3,770
+0.8% +$6.87K ﹤0.01% 3187
2023
Q3 		$929K Buy
464,687
+21,188
+5% +$56.4K ﹤0.01% 3353
2023
Q2 		$1.4M Buy
443,499
+22,322
+5% +$72K ﹤0.01% 3228
2023
Q1 		$1.46M Buy
421,177
+11,448
+3% +$50.3K ﹤0.01% 3164
2022
Q4 		$2.1M Buy
409,729
+25,732
+7% +$243K ﹤0.01% 3019
2022
Q3 		$3.8M Buy
383,997
+100,705
+36% +$1.06M ﹤0.01% 2814
2022
Q2 		$2.38M Buy
283,292
+15,387
+6% +$151K ﹤0.01% 3054
2022
Q1 		$3.37M Buy
267,905
+52,581
+24% +$697K ﹤0.01% 3000
2021
Q4 		$3.42M Buy
215,324
+10,633
+5% +$200K ﹤0.01% 3102
2021
Q3 		$5.15M Buy
204,691
+166,023
+429% +$4.49M ﹤0.01% 2902
2021
Q2 		$1.13M Buy
+38,668
New +$981K ﹤0.01% 3526

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management's IPSC Position: Q1 2026 in Review

Geode Capital Management increased its Century Therapeutics (IPSC) stake by 185% in Q1 2026, buying an estimated $1.78M and bringing the position to 1,301,664 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Geode Capital Management first reported a position in IPSC in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.15M in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Geode Capital Management held 1,301,664 shares of Century Therapeutics worth $2.94M as of Q1 2026.
  • Geode Capital Management bought 845,549 Century Therapeutics shares in Q1 2026, an estimated $1.78M.
  • Century Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2979 holding.
  • Geode Capital Management first reported a position in Century Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Century Therapeutics position peaked at $5.15M in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.